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To the Editor:
In a recent issue of the Journal of
Pediatric Hematology/Oncology, Seki
and colleagues reported on risk factors
for weight gain during induction che-
motherapy in 96 childhood acute lym-
phoblastic leukemia (ALL) patients. In
a retrospective study of medical records,
they found that non–high-risk treat-
ment for childhood ALL and treatment
start date before daily weight measure-
ment were risk factors for weight gain
during induction therapy. They con-
cluded that daily body weight meas-
urements might prevent weight gain
during induction therapy and can result
in maintaining a healthy weight after
ALL treatment.1
We agree that early weight man-
agement should be emphasized, but
question the study’s conclusions because
of its methodological weaknesses. The
retrospective design could have intro-
duced surveillance bias and confound-
ing. During the second half of the study
period (after 2005), more focus was put
on weight management as daily body
weight measurements were initiated in
an attempt to control weight. Patients
who experienced weight gain in the
second half of the study (after 2005) may
have been more closely monitored than
patients in the ﬁrst half of the study
(before 2005). The closer surveillance
could potentially have led to difference
in management, for example, diet
control and water retention. Reverse
causation may have occurred: overall
differences in weight management, not
the daily weight measurements, caused a
weight reduction. More details on how
weight gain found during induction was
handled in the 2 periods would have
helped the reader interpret this study.2 In
the future, an intervention study with
weight monitoring procedures in addi-
tion to normal clinical practice of daily
weight measurements would assist gain-
ing insight into good management of
weight reduction.
The potential misclassiﬁcation of
the outcomes of overweight and obesity
is another bias to be considered. Seki
and colleagues based their body mass
index classiﬁcation on the International
Obesity Taskforce (IOTF) cut-offs
deﬁned in 2000.3 In 2012, the IOTF
published new cut-offs restricted to the
age-range 2 to 18 years.4 Although these
new cut-offs would have only marginally
affected the estimated overweight and
obesity prevalence, because numbers
already were low it would have been
more accurate to have used the newest
cut-offs together with the body mass
index z-score cut-offs deﬁned by the
World Health Organization for those
younger than 2 years. Finally, selective
attrition bias might have occurred in the
subgroup analyses of 40 patients who
did not relapse or have hematopoietic
stem cell transplantation because those
who were excluded seem to have had a
poorer disease status and were more
likely be high risk patients. This could
have resulted in an underestimate
because intense treatment can lead to
weight gain suppression.
We think the results of Seki and
colleagues need to be interpreted with
caution. The power of the study would
have been greater had it had a larger
study population and the analyses been
performed with weight gain as a linear
instead of binary variable. Weight man-
agement is complex; it should encourage
a healthy lifestyle that includes a bal-
anced diet and sufﬁcient physical exercise.
Performing only weight measurements
may increase awareness but not lead
to the long-term lifestyle changes that
are essential in maintaining a healthy
weight.
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